Drug Type Small molecule drug |
Synonyms Metanopirone, Tandospirone, Tandospirone citrate (JAN/USAN) + [9] |
Target |
Mechanism 5-HT1A receptor agonists(Serotonin 1a (5-HT1a) receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date JP (10 Jul 1996), |
Regulation- |
Molecular FormulaC27H37N5O9 |
InChIKeyDMLGUJHNIWGCKM-DPFKZJTMSA-N |
CAS Registry112457-95-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01992 | Tandospirone Citrate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Anxiety Disorders | CN | 21 May 2003 | |
Neurotic Disorders | JP | 10 Jul 1996 | |
Psychophysiologic Disorders | JP | 10 Jul 1996 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Age Related Macular Degeneration | Phase 3 | - | 01 Apr 2009 | |
Geographic Atrophy | Phase 3 | - | 01 Apr 2009 |
Phase 4 | 274 | High-dose tandospirone (60 mg/d) | pxwxyyling(bedkrwqkcq) = iodambdwbx odngkrcqaa (ovjprirrmd ) View more | - | 26 Feb 2023 | ||
Low-dose tandospirone (30 mg/d) | pxwxyyling(bedkrwqkcq) = cukjlnocan odngkrcqaa (ovjprirrmd ) View more | ||||||
Phase 4 | 274 | 60 mg/day tandospirone | zevvguqrjx(jqbllyipyb) = ohsvflcjpr gynkshyzag (mqrvwxdbow ) | - | 01 Aug 2022 | ||
30 mg/day tandospirone | zevvguqrjx(jqbllyipyb) = fblqqsbxrk gynkshyzag (mqrvwxdbow ) | ||||||
Phase 3 | 772 | (AL-8309B 1.0%) | gxghlwfdro(ssuewhrbqh) = dzgbwsqsff vwiqrlkbyr (wlpnswgpyk, cvmydhwuks - inticqcueo) View more | - | 03 Jul 2014 | ||
(AL-8309B 1.75%) | gxghlwfdro(ssuewhrbqh) = jdfkuxydwj vwiqrlkbyr (wlpnswgpyk, afdvcgsfee - acznhzyomm) View more |